You are looking for
Posted on 14.07.2022
The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.
Posted on 02.05.2022
We need to start a conversation now about how to prepare our systems and societies for the changes on the horizon. In the second of a two-part mini-series on predictive genomics, Francesco Floridini examines how Europe can accelerate the transition. I believe technology is no longer the key barrier to unlocking the potential of predictive […]
Posted on 24.07.2019
Digital health has the potential to make healthcare better for patients and for healthcare professionals, as well as to accelerate the shift towards more efficient and cost-effective ways of delivering care. It promises to make healthcare better, safer, and more centred on the patient. Yet, despite this great potential, the people I speak to – […]
Posted on 15.05.2019
20 years ago, I’d have called you foolish if you suggested that the world’s largest taxi company would not own any taxis. I’d have called you ill-advised if you suggested that the world’s largest hotelier would not own any hotels. I’d have thought you unwise if you suggested that the world’s largest book store could […]
Posted on 29.04.2015
2015 has been predicted, by many commentators, as the year that digital health will officially ‘’take off’’ due to increased consumer-wide acceptance, a growing array of digitally enabled health applications and increased investment levels. All of these factors are contributing to the cause for more and more leading consumer brands to enter into the digital […]
Posted on 09.07.2014
In September 2013 I went for a truly inspirational bike trip across 5 countries, covering over 2100 km from Brussels to Barcelona. Many of my fellow cyclists were Type 1 diabetics and the trip was organized to give insight into how issues of interoperability can be resolved.
The fundamental problem facing people with diabetes (PWD) is keeping their Blood Glucose (BG) levels within a normal range. To do this PWD use devices to monitor their BG levels. These devices provide a reading that is then used to make therapeutic decisions such as taking insulin or treating a low reading by eating.
“Nihil novi sub sole” said the Vulgate. That could not be farther from reality when it comes to the MedTech Europe blog. And I am privileged to be the first author to “lay pen to paper” and contribute to MedTech Views, an initiative by MedTech Europe to establish a true platform for dialogue about medical technologies. No priority is given to any one healthcare stakeholder, and everyone has the opportunity to submit their view as we strive to have an open exchange of opinions on the new platform.
The impressive spread of mobile connectivity in recent years has attracted attention on the infinite possibilities to transform healthcare services, making them accessible to people regardless of their age, social status or geographical location. Thousands of mobile applications have been developed and hundreds of pilot studies have been launched in an attempt to capture a slice of the pie. With increasing prevalence of cancer and rocketing healthcare costs, could mHealth be a solution for cancer supportive care? We dig in to find out.